Earnings Outlook For Amneal Pharmaceuticals

Amneal Pharmaceuticals AMRX will release its quarterly earnings report on Friday, 2024-11-08. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Amneal Pharmaceuticals to report an earnings per share (EPS) of $0.13.

Anticipation surrounds Amneal Pharmaceuticals's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Historical Earnings Performance

Last quarter the company beat EPS by $0.02, which was followed by a 0.0% drop in the share price the next day.

Here's a look at Amneal Pharmaceuticals's past performance and the resulting price change:

Market Performance of Amneal Pharmaceuticals's Stock

Shares of Amneal Pharmaceuticals were trading at $8.5 as of November 06. Over the last 52-week period, shares are up 103.2%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

To track all earnings releases for Amneal Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.